Advanced Oncotherapy

Advanced Oncotherapy is a specialist developer and provider of the next generation of particle therapy systems that makes radiation less toxic for patients. Our aim is to create a bright future in cancer care with our advanced LIGHT technology. Vision: To develop a more affordable proton-based radiotherapy system, using an innovative and clinically more effective technology, and saving more cancer lives. Mission: To facilitate the wider use of radiation with protons for treating all forms of radio-sensitive cancers by commercialising a novel technology, and building on the success and scientific know-how of CERN (Centre Européen pour la Recherche Nucléaire).
London, GB
Size (employees)
51 (est)
Advanced Oncotherapy was founded in 1994 and is headquartered in London, GB

Advanced Oncotherapy Office Locations

Advanced Oncotherapy has offices in London, Syracuse and Rolle
London, GB (HQ)
4-7 Manchester St
Rolle, CH
23 Route de Genève
Syracuse, US
1009 E Fayette St

Advanced Oncotherapy Data and Metrics

Advanced Oncotherapy Financial Metrics

Advanced Oncotherapy's revenue was reported to be £84.2 k in FY, 2015 which is a 21% decrease from the previous period.

Revenue (FY, 2015)

84.2 k

Revenue growth (FY, 2014 - FY, 2015), %


Gross profit (FY, 2015)

(25.5 k)

Gross profit margin (FY, 2015), %


Net income (FY, 2015)

(5.8 m)

Market capitalization (25-Jul-2017)

11.4 m

Closing share price (25-Jul-2017)


Cash (31-Dec-2015)

9 m
Advanced Oncotherapy's current market capitalization is £11.4 m.
GBPFY, 2013FY, 2014FY, 2015


68.9 k106.4 k84.2 k

Revenue growth, %


Cost of goods sold

156 k202.7 k109.7 k

Gross profit

(87 k)(96.3 k)(25.5 k)

Gross profit Margin, %


Operating expense total

3.1 m5.7 m8.5 m

Pre tax profit

(3.4 m)(5.7 m)(8.6 m)

Net Income

(3.4 m)(5.7 m)(5.8 m)
GBPFY, 2013FY, 2014FY, 2015


148.8 k1.5 m9 m

Accounts Receivable

28.6 k73.6 k

Current Assets

1.4 m3.2 m16.7 m


2.7 m2.1 m1.3 m


8.2 m9.2 m12.7 m

Total Assets

12.3 m14.5 m30.7 m

Accounts Payable

722.5 k1.1 m342 k

Current Liabilities

5.4 m3.3 m3.5 m

Total Liabilities

5.4 m3.3 m3.5 m

Retained Earnings

(3.9 m)(7.5 m)(6.6 m)

Total Equity

6.9 m11.1 m27.3 m

Financial Leverage

1.8 x1.3 x1.1 x
GBPFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

(2.9 m)(6.6 m)(9.8 m)

Cash From Financing Activities

2.5 m9.2 m21.1 m

Income Taxes Paid

2.8 m
GBPY, 2015


2.9 k

Financial Leverage

1.1 x

Advanced Oncotherapy Market Value History

Traffic Overview of Advanced Oncotherapy

Advanced Oncotherapy Online and Social Media Presence

Advanced Oncotherapy News and Updates

Advanced Oncotherapy Company Life and Culture

You may also be interested in